CD27 and primary biliary cholangitis: Our study indicates that an increased proportion of IgD- CD27- %lymphocytes lowers the risk of PBC and explores the potential pathogenic mechanisms of PBC through genetic means, charting a course for the discovery of novel pharmacological targets and delineating new prospects for drug development.